000 01539 a2200457 4500
005 20250513012247.0
264 0 _c19830415
008 198304s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-198212000-00015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDresdale, A R
245 0 0 _aProspective randomized study of the role of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathy.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cDec 1982
300 _a657-63 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAcetylcysteine
_xtherapeutic use
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aCardiomyopathies
_xchemically induced
650 0 4 _aChild
650 0 4 _aDoxorubicin
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHeart Function Tests
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRandom Allocation
650 0 4 _aSarcoma
_xdrug therapy
650 0 4 _aSoft Tissue Neoplasms
_xdrug therapy
700 1 _aBarr, L H
700 1 _aBonow, R O
700 1 _aMathisen, D J
700 1 _aMyers, C E
700 1 _aSchwartz, D E
700 1 _ad'Angelo, T
700 1 _aRosenberg, S A
773 0 _tAmerican journal of clinical oncology
_gvol. 5
_gno. 6
_gp. 657-63
856 4 0 _uhttps://doi.org/10.1097/00000421-198212000-00015
_zAvailable from publisher's website
999 _c7164600
_d7164600